Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07121738 · ClinicalTrials.gov registry record · NA
A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer
A NA study of Gynecologic Cancers, sponsored by AdventHealth.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT07121738: Recruiting NA study of Gynecologic Cancers, sponsored by AdventHealth.
NCT07121738 is a NA study of Gynecologic Cancers that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 64 participants, below the 428-participant average among 10 other Gynecologic Cancers trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07121738, a NA study of Gynecologic Cancers, is actively recruiting participants, sponsored by AdventHealth.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program on participants' 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers.
Primary Outcome
A 20-item questionnaire measuring eating self-efficacy across five domains: negative emotions, availability, social pressure, physical discomfort, and positive activities. Each item is rated on a 10-point scale (0 = Not confident, 9 = Very confident) for the participant's ability to resist overeating in various situations. Higher scores indicate greater confidence in managing eating behaviors (higher eating self-efficacy).
Conditions Studied
Interventions
- BEHAVIORAL Healthy Eating Active Lifestyle (HEAL): Gyn Cancer Program
Study Locations (1)
Florida
- AdventHealth - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT07121738 shows while recruiting
NCT07121738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 428-participant average among 10 other Gynecologic Cancers trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Gynecologic Cancers appearing as the primary indexed condition, and to 1 intervention - of which Healthy Eating Active Lifestyle (HEAL): Gyn Cancer Program is the first listed.
NCT07121738 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07121738 about?
NCT07121738 is a clinical study titled "A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer". This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program on participants' 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers.
What is the current status of trial NCT07121738?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-12-08. Estimated completion is 2026-08-31.
What conditions does trial NCT07121738 study?
This clinical trial studies the following conditions: Gynecologic Cancers.
What interventions are being tested in trial NCT07121738?
The interventions under investigation include: Healthy Eating Active Lifestyle (HEAL): Gyn Cancer Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07121738?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07121738 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07121738's enrollment target sits among peer trials
64 5th of 10 higher than 6 of 10 other Gynecologic Cancers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gynecologic Cancers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Proactive Costs of Care Study
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Communication About Sexual Health in Gynecologic Cancer
RECRUITING · NA
-
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
RECRUITING · Phase 1
-
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
RECRUITING
-
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI